Amicus Therapeutics' (FOLD) shares rise more than 5% in recent Thursday trading after Needham upgraded the company's stock to buy from hold, with a price target of $14.
Trading volume stood at over 4.6 million shares compared with a daily average of roughly 4.5 million.
Price: 8.38, Change: +0.41, Percent Change: +5.08